Sudarshan Pharma Industries Balance Sheet Health
Financial Health criteria checks 2/6
Sudarshan Pharma Industries has a total shareholder equity of ₹1.2B and total debt of ₹1.2B, which brings its debt-to-equity ratio to 105.6%. Its total assets and total liabilities are ₹3.2B and ₹2.0B respectively. Sudarshan Pharma Industries's EBIT is ₹294.2M making its interest coverage ratio 2.6. It has cash and short-term investments of ₹19.2M.
Key information
105.6%
Debt to equity ratio
₹1.24b
Debt
| Interest coverage ratio | 2.6x |
| Cash | ₹19.17m |
| Equity | ₹1.18b |
| Total liabilities | ₹2.03b |
| Total assets | ₹3.20b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 543828's short term assets (₹2.6B) exceed its short term liabilities (₹1.9B).
Long Term Liabilities: 543828's short term assets (₹2.6B) exceed its long term liabilities (₹95.9M).
Debt to Equity History and Analysis
Debt Level: 543828's net debt to equity ratio (104%) is considered high.
Reducing Debt: 543828's debt to equity ratio has increased from 91.5% to 105.6% over the past 5 years.
Debt Coverage: 543828's debt is not well covered by operating cash flow (4.8%).
Interest Coverage: 543828's interest payments on its debt are not well covered by EBIT (2.6x coverage).